Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of a New Diagnostic Device to Assess Small Intestinal Dysbiosis in Routine Clinical Setting.

NCT04910815 is registered in ClinicalTrials.gov with Atmo Biosciences Pty Ltd as lead sponsor.

NCT NCT04910815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04910815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of a New Diagnostic Device to Assess Small Intestinal Dysbiosis in Routine Clinical Setting.
Lead sponsor
Atmo Biosciences Pty Ltd
Phase
Not applicable
Overall status
Unknown status
Start date
July 14, 2021
Completion date
August 1, 2024
Enrollment
150 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

small intestinal bacterial overgrowth